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ABSTRACT 
 
Multispectral Segmentation of Whole Brain MRI 
 
Nitya Krishnan 
 
 
Magnetic Resonance Imaging (MRI) is a widely used medical technology for diagnosis 
and detection of various tissue abnormalities, tumor detection, and in evaluation of either 
residual or recurrent tumors. This thesis work exploits MRI information acquired on 
brain tumor structure and physiological properties and uses a novel image segmentation 
technique to better delineate tissue differences.  
 
MR image segmentation will be important in distinguishing between boundaries of 
different tissues in the brain. A segmentation software tool was developed that combines 
the different types of clinical MR images and presents them as a single colored image. 
This technique is based on the fuzzy c - means (FCM) clustering algorithm. The MR data 
sets are used to form five-dimensional feature vectors. These vectors are segmented by 
FCM into six tissue classes for normal brains and nine tissue classes for human brains 
with tumors. The segmented images are then compared with segmentation performed 
using Statistical Parametric Mapping (SPM2)-software that is commonly used for brain 
tissue segmentation. The results from segmenting the whole volume MRI using FCM 
show better distinction between tumor tissues than SPM2.  
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 Chapter 1   
 
Introduction 
Magnetic resonance imaging (MRI) is used as a medical diagnostic tool for studying the 
human anatomy. MRI is based on the principles of nuclear magnetic resonance (NMR), a 
technique that provides information about properties of materials. NMR was developed 
by Bloch and Purcell in the 1940’s. In the 1970's Paul Lauterbur, Ray Damadian, and 
Peter Mansfield began to use the principles of NMR in MRI as an imaging modality in 
the head, spine and body.  MRI produces images of high spatial resolution (mm) with 
good soft tissue contrast that has made it useful for detection of diseases. In 2003, Paul 
Lauterbur and Peter Mansfield were awarded the Nobel Prize in Physiology or Medicine 
for their simultaneous pioneering research using magnetic resonance to image the human 
body.  
 
The focus of this thesis is the use of MRI in brain tumors utilizing their physiological 
properties and using image segmentation techniques to obtain better delineation. MRI is a 
commonly used modality for detection of brain tumor, their spread and in evaluating 
residual or recurrent brain tumors. The growth in technology allows for improved tumor 
detection and biological characterization of the tumor. Brain tumor detection is an 
important application which continues to be of keen interest to clinicians. MR imaging is 
utilized for tumor biopsy planning, treatment monitoring, and long term monitoring for 
reoccurrence.  
 
Current clinical methods that are used to differentiate tumors from normal tissues, even 
after the injection of a contrast medium, may not detect all tumors and sometimes tumors 
may not enhance well. Hence, there is a need to combine the various MRI data sets to 
classify brain tissues and differentiate them from abnormal tumor tissues. In particular, 
current brain segmentation methods like Statistical Parametric Mapping (SPM2) fail for 
brain images of patients with brain lesions. This is due to the fact that SPM uses a priori 
probability images for segmentation and in the case of patient data there is no valid a 
 1
 priori model. In this thesis, a software tool in MATLAB has been developed for 
segmenting whole volume MRI data sets using the Fuzzy c-means (FCM) clustering 
algorithm.  
 
Principles of MRI 
Nuclei with odd number of protons and neutrons have a non-zero nuclear magnetic 
moment. The hydrogen nucleus, composed of a single proton, has the largest magnetic 
moment and is abundantly found in the body tissues (since the human body mostly 
consists of water, 1mm3 of water = 6.7x1019 hydrogen protons). Hence, the hydrogen 
proton is the primary nucleus used for MRI because it produces the strongest signal. The 
proton precessing in the absence of an external magnetic field may be oriented along any 
direction as shown in Figure 1.1. 
 
 
 
 
 
 
Figure 1.1 Proton alignment in the absence of magnetic field1. 
 
The net magnetic moment per unit volume known as the magnetization vector is given 
by: 
M = Mx i + My j + Mz k     (1.1) 
Where M – magnetization vector in the x, y, z direction, i, j, k are unit vectors. 
 
In the absence of an external magnetic field, the net magnetization vector M will be zero.  
When placed in a strong external magnetic field , the magnetic moments of the proton 
align (orient) themselves along the magnetic flux lines and precess about the flux lines. 
The magnetic moments of the protons precess along the z-direction (in the direction of 
) as shown in Figure 1.2. 
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Figure 1.2 Protons in a magnetic field aligned along external magnetic field 10B . 
 
The equilibrium value of the magnitude of proton magnetization , (average of all 
individual nuclear magnetic dipole moments), in the presence of magnetic field  is 
given as:  
0M
0B
s
0
22
0 3kT
B)1I(IhNM += γ  (1.2) 
Where, 
0B - Static magnetic field, 
N  - Number of proton spins per unit volume,  
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 γ  - Gyromagnetic ratio, a constant unique for each nucleus, 
h  - Planck’s constant, 
I  - Proton spin,  
Ts  - Absolute sample temperature in Kelvin, 
k  - Boltzmann’s constant.  
 
Thus magnetization  is proportional to external magnetic field . The magnetic 
moments exhibit the property of precessing around the field . The frequency of 
precession is given by the Larmor frequency: 
0M 0B
0B
π
γ
2
B
f 0L =  (1.3) 
For the proton, 58.42
2
=π
γ MHz / Tesla, thus the Larmor frequency will be in 
radiofrequency region (40-50 MHz). The Larmor frequency is proportional to the 
magnetic field strength  from Equation 1.3. 0B
 
To obtain an MR signal, radiofrequency (RF) pulses of electromagnetic radiation B1 are 
applied at the Larmor frequency Lf  perpendicular to the main magnetic field, 
disturbing the magnetic moments of the protons from their equilibrium position0B 2. The 
protons are aligned along the z-axis in equilibrium with the longitudinal magnetization 
(Mz) of magnitude . This alignment, when disturbed by a 90 degree RF pulse 
displaces M
0M
z to Mxy. The total displacement is proportional to the RF-pulse energy and 
also the Larmor frequency. If the energy of the RF pulse is sufficient to tip the 
magnetization vector by 90 degrees (tip angle), then Mz is tipped into the transverse 
plane (x, y). The magnetization vector continues to precess about in the transverse 
plane. This time-varying magnetization induces flux changes which are detected in a RF 
coil.  The interaction of a proton with the magnetic field is shown in Figure 1.3. 
0B
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Figure 1.3 Interaction of a proton with magnetic field - a) An RF-pulse creates the 
opposed field B1, displacing Mz and causing the precession about the z-axis. b) A large 
RF-pulse displaces Mz into the transverse plane (z-component is zero; x, y components 
are maximum) 3.  
 
The protons when returning to their equilibrium position along the z-axis undergo 
relaxation processes which can be described in two ways: The relaxation component of 
the net magnetization vector along the z-axis is called longitudinal or spin-lattice 
relaxation and this time constant is called T1. The relaxation component of net 
magnetization vector in the xy plane is called transverse or spin-spin relaxation and this 
time constant is called T2. 
 
Relaxation constants 
After a 90 degree RF pulse excitation, the return of the longitudinal component of 
magnetization to its equilibrium state along the z-direction is termed the longitudinal or 
spin-lattice relaxation. The T1 relaxation is due to the loss of energy by the protons to the 
surrounding nuclei as they return to their equilibrium state. The T1 relaxation is 
approximately an exponential process and is specified in milliseconds. T2 relaxation is 
the decay of transverse magnetization, also an exponential process, represents the overall 
loss of phase coherence due to dephasing of the spins. Each proton has unique T1 and T2 
time constants depending on the surrounding environment. The T2 time constant is 
typically about 10-1000 milliseconds long. The T2 spin dephasing can also be caused by 
tissue inhomogeneities, field inhomogeneities, or tissue interfaces. These 
inhomogeneities further reduce the relaxation constant and T2 is called the effective T2 or 
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 T2* time constant. The T2* time constant is much shorter than T2. The relaxation constants 
are important parameters of MR and are different for various brain tissues as shown in 
Table 1.  
Table 1: Approximate values of T1 and T2 at 1.0 Tesla4. 
Tissue T1(msec) T2(msec) 
White matter 390 90 
Gray matter 520 100 
Cerebrospinal Fluid (CSF) 2000 300 
Muscle 600 40 
Fat 180 90 
Liver 270 50 
Blood 800 180 
 
Image Contrast 
In MR images, the magnitude of the MR signal is represented by the intensity of each 
pixel in the image. Contrast in the images depends on the pulse sequences used, and also 
on the tissue characteristics. The type of image produced depends on the TR and TE 
values. TR is the repetition time of the 90 degree pulse and TE is the echo time, the 
amount of time between the RF excitation and the measurement of the echo. The 
relaxation constants T1 and T2 provide good sources of contrast and by varying TR and 
TE the desired contrast can be obtained as shown in Figure 1.4. Varying these parameters 
along with different sequences allow different tissue types and pathologies to be 
highlighted. Radiologists, trained to interpret MRI scans, use these varied contrast 
images to detect abnormalities. A T1-weighted image is characterized by short TR and 
short TE values. A T2-weighted image has a long TR and a long TE value.  A proton 
density image has a long TR and a short TE value. Image contrast can also be changed by 
the exogenous contrast agents that have paramagnetic properties like gadolinium-
diethylene triamine penta-acetic acid dimeglumine (Gd-DTPA). Shown in Figure 1.4 are 
T1-weighted and T2-weighted images taken by a 3T scanner.  
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 Figure 1.4 Example of MRI a) T1-weighted image b) T2-weighted image 
 
Bloch Equation 
During relaxation, the protons trace a spiral motion which can be described by the Bloch 
equation5. The equation of motion of magnetization around the total magnetic field 
present is given by the Bloch equation as:  
BMM ×= γ
dt
d  (1.4) 
Where:  
B  - Total magnetic field 
M - Magnetization vector 
γ  - Gyromagnetic ratio 
 
The Bloch equation states that the time rate of change of M is proportional to the cross 
product of M with γ B. Hence if B is static, this motion corresponds to a precession of M 
about B at an angular frequency of γ B . If B is time varying, then the precessional 
frequency also becomes time varying. The Bloch equation can be written to include the 
relaxation constants T1 and T2 and is given by: 
             
( ) ( )
1
0
2 T
M
T
kMjMiM
BMM zyx
−−+−×= γ
dt
d
 (1.5) 
Where:  
B - Total magnetic field 
M - Magnetization vector 
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 γ  - Gyromagnetic ratio 
T1  - spin lattice (longitudinal – z) relaxation time constant  
T2  - spin-spin (transverse-xy) relaxation time constant 
M0 - equilibrium magnetization due to 0B
Mx, My, Mz - magnetization in the x, y, z plane respectively 
i, j, k - unit vectors in x, y, z directions respectively.    
 
The solution to the modified Bloch equation is shown below: 
                   
)e(tsin)t(
)e(tcos)t(
)e1(M)t(
2
2
1
T/t
0
T/t
0
T/t
0
−
−
−
ω−=
ω=
−=
xyy
xyx
z
MM
MM
M
(1.6) 
 
Signal Measurement  
After the application of the RF pulses, emissions by the protons of RF radiation by the 
relaxation process at the resonant frequency take place. Flux changes are detected in the 
receiver coil and the precessing magnetization in the transverse direction gives rise to an 
electromotive force ∈  which is given as the rate of change of flux (ϕ ) in the coil. 
t∂
ϕ∂−∈=  (1.7) 
If B1(x, y, z) is the magnetic field at a point (x, y, z), the EMF in the coil is given as:  
( ) ( ){ } rMB1 dt,z,y,xz,y,xtd •∂
∂−∈=  (1.8)
Thus the total EMF signal s(t) is given as: 
( ) ( ){ } rMB1 dt,z,y,xz,y,xt)t(sd
vol vol
•∂
∂−=∈=∫ ∫   (1.9) 
The voltage is then amplified and demodulated to provide the MR signal. 
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 Signal Localization using Gradients 
Within the magnet, gradient coils are placed so that they superimpose their fields on the 
main magnetic field . A set of gradient coils provide varying magnetic field strengths 
along the x (G
0B
x), y (Gy) and z (Gz) direction. Gradients change only the spatial variation 
of the amplitude of 0B  and not the direction of .0B  Thus the gradient coils in the three 
directions permit spatial information to be obtained. Switching between the three 
gradients allows for image data signals to be obtained. Simplifying from Equation 1.8 
and adding gradient fields G(t) in x and y direction, the received signal from an excited 
slice can be written as: 
( ) dxdyeey,xm)t(s y)t(k2ix)t(k2i
x y
yx π−π−∫ ∫=  (1.10)
Thus the intensity of the signal is proportional to the magnitude of the magnetization.  
 
The above equation can be compared with 2-D Fourier transform of m(x, y) given as: 
( )∫ ∫ +π−=
x y
)ykxk(2i
yx dxdyey,xm)k,k(M yx  (1.11) 
From Equation 1.10 and 1.11 we obtain the signal equation as: 
)k,k(Md)(G
2
,d)(G
2
(M)t(s yx
t
0
y
t
0
x =ττπ
γττπ
γ= ∫∫  (1.12) 
Thus at any given time, the signal s(t), equals the value of the 2D Fourier transform of 
m(x, y). Thus the total signal obtained s(t), is mapped to a trajectory through Fourier 
space. In MRI, raw data is stored in 2D Fourier space called “k” space, where k 
represents the spatial frequency variable. In order for the signal to be reconstructed, the 
trajectories of s(t) need to cover a sufficient amount of k space. The k space data is then 
2-D Fourier transformed to obtain the MR image.  
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 Pulse Sequences 
A pulse sequence is a term used to describe the ensemble of RF pulses (and gradient 
magnetic field pulses) of defined time and amplitude repeated a specified number of 
times, resulting in the accumulation of MR signal which is then Fourier transformed to 
form the MR image6.  The most common types of pulse sequences used are: spin-echo 
(SE) and gradient-recalled-echo (GRE).  The type of pulse sequence chosen also 
determines the contrast observed in the MR image. 
 
Spin-Echo Pulse Sequence (SE): 
The spin-echo pulse sequence commences with a 90 degree RF pulse which shifts the 
magnetization vector into the transverse plane yielding a free induction decay (FID) 
signal.  A slice select gradient is applied during this time in order to selectively excite the 
protons in the desired slice. Next, a phase encoding gradient is turned on for specified 
time period and switched off. This gradient is used to distribute the phase of the spins 
according to their spatial locations. The amplitude of the gradient is varied as seen in 
Figure 1.5 in order to spatially encode the spins within the slice. At a time of TE/2 after 
the 90 degree pulse, a 180 degree RF pulse is applied to the slice protons to achieve spin 
rephasing of the FID signal. “Echoes” (transverse magnetization reappears and forms an 
echo) are obtained at time TE after the initial 90 degree pulse.  It can be seen from Figure 
1.5 that the slice select gradient is turned on again during the 180 degree RF pulse. This 
gradient is particularly useful for multislice spin-echo imaging. Further echoes can be 
obtained by applying additional 180 degree pulses and this is called fast spin-echo 
imaging. The final step of spin-echo imaging is the readout of the echo signal. The 
readout gradient is applied while data acquisition takes place. During the read out 
gradient, frequency encoding of the spins along the readout direction takes place.  The 
echo-to-echo amplitude decays as a function of T2.  Spin-echo sequences can be used to 
obtain T1-weighted images, T2-weighted or proton density weighted images (PD).  A 
spin-echo pulse sequence is shown below:  
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Figure 1.5 Spin-echo pulse sequence1. 
RF 
Phase encoding gradient
 
Sampling timeDephase 
Frequency-selection gradient / read-out 
Slice Slice
180° RF "sinc" pulse 
4 msec
90° RF "sinc" pulse 
SI 
FID Spin-echo
 
Gradient-Recalled-Echo Pulse Sequence (GRE): 
Gradient-recalled-echo imaging reverses the polarity of the gradient field rather than 
using a 180 degree RF pulse to invert the spins to generate an echo as seen in Figure 1.6. 
A gradient reversal in the readout direction is used. Hence the signal intensity for a given 
TE is a function of the effective T2, called T2*, rather than T2 as in spin-echo method. The 
advantage of using a gradient-echo method is that it is a faster imaging method with 
sensitivity to T2* contrast and also uses reduced flip angle and gradient reversal instead of 
a 180 degree RF pulse. It uses a shorter echo time (TE) and without the rephasing RF 
pulse, dephasing occurs more rapidly in gradient-echo imaging. The gradient-recalled-
echo method is particularly sensitive to signal loss at boundaries of bone and tissue or air 
and tissue. In spin-echo sequence, the use of gradient pulses increases the length of the 
echo time (TE) and uses long TRs which increase the scan time. A gradient-recalled-echo 
sequence is shown in Figure 1.6. 
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SI 
Slice selection gradient  
FID 
 RF sinc pulse - flip angle (α°) 
4 msec 
Dephase 
Sampling time 
Echo 
Slice 
Figure 1.6 Gradient-recalled-echo pulse sequence1. 
 
 
In this thesis the segmentation algorithm is applied to whole brain MR images with 
tumors. In order to understand the clinically important characteristics to appropriately 
segment the tumor tissues, it is necessary to understand the tumor types, physiology and 
metabolism of tumors. 
 
Brain Tumors 
A tumor is a growth of abnormal cells reproducing themselves in an uncontrolled 
manner. Brain tumors occur either in the brain (as primary brain tumors) or can spread 
from other parts of the human body to the brain (metastatic brain tumors). There are two 
types of brain tumor according to the National Cancer Institute7: 
• Benign brain tumor consists of abnormal cells and such tumors have distinct 
boundaries. The cells are slow growing and do not spread or infiltrate and can be 
removed if they are not located in sensitive areas of the brain. 
• Malignant brain tumor consists of cells that have no distinct separation from healthy 
cells. These cells destroy the surrounding tissues and then spread to other parts of the 
brain in an uncontrollable manner. 
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 Most brain tumors are named after the cells from which they arise. Some of the primary 
brain tumors are: astrocytomas, glioblastoma, oligodendroglioma, and ependymoma. The 
World Health Organization (WHO) has developed a scheme for classifying and grading 
tumors. The grading is based on factors such as location, cell types, growth of blood 
vessels (vascular proliferation), dividing cells (mitotic activity), pathological variation in 
the appearance of the cells (nuclear atypia) and amount of dead cells or tissues 
(necrosis)8.  The different types of brain tumors according to their grade are shown in 
Table 2. 
Table 2: Tumor Grade8 
Grading Histological criteria 
Grade I & II Exhibit nuclear atypia 
Grade III High cellular density, nuclear atypia, mitotic activity 
Grade IV 
Nuclear atypia, mitotic activity, proliferation &/or 
necrosis. 
 
Low grade tumors (Grade I) of the brain are generally not well encapsulated unlike other 
tumor types but exhibit slow growth. Since they are slow growing and are relatively non-
invasive they are considered to be relatively benign.   
 
Grade II tumors are also considered to be slow growing but they are said to have more 
poorly defined margins. Surgical treatments for these tumors are difficult as their 
boundaries are poorly defined.  
 
Grade III tumors have a faster growth pattern and they are called “anaplastic”. These 
tumors exhibit histological signs of nuclear atypia and mitotic activity. Many low grade 
tumors develop slowly into anaplastic tumors. These tumors grow their own blood 
vessels (angiogenesis) and invade the surrounding tissues. 
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Grade IV tumors are said to be highly malignant and exhibit very rapid growth. Grade IV 
tumors also exhibit histological signs such as mitotic activity, proliferation, and/or 
necrosis. The existing knowledge about each tumor helps the clinicians in determining the 
course of treatment at each step.  
 
Types of Brain Tumors 
About 50 percent of the primary brain tumors in adults are astrocytomas. These arise 
from the astrocyte cells that are fibrillary and attach to the blood vessels. Astrocytomas 
occur primarily in the cerebral hemispheres. Most of the low grade astrocytomas also 
known as pilocytic astrocytoma are usually non-infiltrating tumors. They are usually 
considered benign and surgery can remove most of this cyst-like tumor. Grade II 
astrocytomas are infiltrating although they grow slowly. These astrocytomas are grouped 
according to their appearance and behavior. Some examples of grade II astrocytoma are: 
fibrillary, gemistocytic, and protoplasmic. Even after removal of this type of tumors, they 
might recur as high grade tumor. About 33 percent of the infiltrating astrocytomas mutate 
and progress from low grade astrocytoma to anaplastic astrocytoma (malignant). The 
anaplastic astrocytomas have projections like tentacles that grow into the surrounding 
tissues making it more difficult to completely remove them. About 20 percent of all the 
primary brain tumors are the grade IV glioblastoma multiforme (GBM). They are also 
known as grade IV astrocytomas. The glioblastoma tumors are capable of very rapid 
growth and usually contain necrotic cells and blood vessels. 
 
Gliomas are cancerous cells originating from glial cells. Malignant gliomas show 
prominent proliferation of microvasculature and have the ability to form blood vessels 
(angiogenesis).  An oligodendroglioma tumor arises from an oligodendrocyte cell and an 
ependymoma arises from ependymal cells of the brain.  
 
Tumor metabolism is influenced by many factors of which tumor vasculature is one 
important factor9. Once tumor starts to grow rapidly, the tumor cells induce vascular 
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 growth called tumor angiogenesis, a process of formation of new blood vessels from 
existing normal blood vessels. The smallest vessels, such as the capillaries, arterioles, and 
venules known as microvasculature assists the growth of tumor cells by supplying 
nutrients and oxygen.  
 
Vascularization largely varies the physiology and metabolism of tumors resulting in 
hypoxia, substrate deprivation, and pH variations. Tumor vasculature is more chaotic; 
leaky and not enervated10 and hence there is an insufficient supply of oxygen and 
nutrients to the tumors. The amount of oxygen in the tumor can be of significant 
importance as the amount of oxygen supply to tumor cells can affect the therapy 
treatment since hypoxic tumor cells are more resistant to therapy than well-oxygenated 
tumors. This is due to the fact that cellular damage caused by ionization radiation largely 
depends on the concentration of oxygen in tissues11. Hence it becomes important to 
estimate the oxygen content in tumor cells. Imaging techniques help to analyze the entire 
lesion for further treatment. In addition, determining the amount of necrotic (dead) tissue 
has implications for understanding the efficacy of the treatment and the vascular supply 
to the tumor. 
 
MR based imaging techniques are used to characterize brain tumors according to their 
anatomy and physiology, particularly clinicians are interested in determining tumor 
location, extent, amount of necrosis, vascular supply, and associated edema. There are 
different imaging techniques that are useful. The specific aim of these techniques is to 
provide a relevant differential diagnosis. The various techniques used today for imaging 
brain tumors are listed below and is explained in detail in Chapter 2. 
? Fast fluid-attenuated inversion-recovery (FLAIR) imaging. 
? Diffusion-weighted imaging (DWI). 
? Perfusion imaging (PWI). 
? Gd-DTPA enhanced contrast imaging 
? MR spectroscopy imaging. 
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 Chapter 2  
 
MR Imaging Methods 
MRI, known for its soft tissue contrast, is very useful in evaluating brain tumors. MRI 
based functional techniques and spectroscopic techniques provide more physiological 
information than the standard T1-weighted and T2-weighted imaging. Functional imaging 
provides information about vasculature and tissue perfusion, and optimizes tumor 
characterization. Following radiotherapy treatments, some tumors may not enhance even 
while imaging with contrast medium or the enhancement may not indicate malignancy. 
The concentration curves (rCBV) using perfusion imaging help in quantifying the 
regional blood flow and volume of a given tumor region. These concentration curves and 
quantifications will help to determine the remaining tumor region or reoccurrences. MR 
spectroscopy and spectroscopic imaging allows for measurement of the metabolites of the 
tumor tissue. These improved techniques give insight to the tumor vasculature, its 
metabolism, permeability and microcirculation. Different methods of imaging are applied 
in the clinical environment according to the tumor type and diagnostic requirements.  
Some of the methods used in this thesis work are described in detail below. 
 
Fast Fluid - Attenuated Inversion-Recovery (FLAIR) 
Fast fluid - attenuated inversion - recovery is a pulse sequence that produces T1-weighted 
or T2-weighted images with the cerebrospinal fluid (CSF) nulled. This is done by 
applying an inversion RF pulse before the regular 90 degree pulse sequence. Since the 
CSF signal is removed, lesions may appear hyperintense in these images. FLAIR is very 
useful in differentiating and detecting brain tumors. FLAIR is superior to T2-weighted 
images in distinguishing tumor and edema even though it has the drawback that 
periventricular tumors may go undetected12. 
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 Diffusion - Weighted Imaging (DWI) 
Diffusion - weighted imaging (DWI) is a MRI technique in which contrast within the 
image is based on the movement of water molecules. The notation diffusion represents 
the random movement of molecules also known as Brownian motion.  In pure water, the 
diffusion of water molecules is completely random; however in a cellular environment 
diffusion is not completely random and is restricted by cellular boundaries and 
macromolecules.   
 
Using MR imaging, the diffusion properties of water molecules can be measured13. In 
clinical imaging, the tissue diffusion coefficient is denoted by a quantity called the 
apparent diffusion coefficient (ADC). ADC values are calculated as a representation of 
relative diffusion restriction. Diffusion is the highest in the ventricles which contain the 
cerebrospinal fluid (CSF) in the human brain. Hence, in DWI of the normal brain, the 
ventricles appear less intense than brain parenchyma since diffusion is higher in 
ventricles compared to parenchyma14.  Diffusion-weighted MRI sequences are formed by 
adding a pair of magnetic field gradients to the spin-echo or spin-echo echo-planar pulse 
sequences.  The first gradient is applied after the initial 90 degree pulse as shown in 
Figure 2.1. This dephases the spins. After the 180 degree pulse, a second gradient is 
applied which opposes the effect caused by the first gradient. If there is movement of the 
water protons between the two gradients, refocusing of the moving spins is incomplete, 
which will result in reduced signal intensity (in areas of high diffusion). The amount of 
diffusion sensitivity to a particular sequence is denoted by a b-value and is defined in 
Equation 2.2.  A higher b-value provides stronger diffusion weighting.  The signal 
intensity at a particular voxel in a diffusion-weighted MR image can be represented by 
Equation 2.1 and is called the Stejskal-Tanner equation15. 
⎥⎦
⎤⎢⎣
⎡ ⎟⎠
⎞⎜⎝
⎛ δ−∆δγ≈ ADC
3
G-expSI 222  (2.1)
( ) ( 3/Gb 2 δ−∆δγ= )  (2.2) 
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 Where, 
b - Amplitude and timing parameters of the gradient pulses, 
G - Amplitude of the gradient pulses, 
δ  - Duration of the gradient pulse, 
∆  - Time interval between gradient pulses, 
 γ  - Gyromagnetic ratio. 
Figure 2.1 Diffusion - weighted imaging pulse sequence15. 
 
The attenuation caused by diffusion is calculated by comparing the images between the 
two b-values (say b=0 and higher b value). ADC maps are then calculated by fitting a 
linear least-squares analysis on a set of diffusion-weighted images.  
 
Diffusion - Weighted Imaging of Tumors 
Diffusion-weighted imaging helps in tumor grading and also in differentiating tumors 
from edema. Previous studies have correlated the ADC values to tumor cellularity and 
signal intensity16.  It has been shown that highly cellular gliomas (higher grade) display 
lower ADC values than low grade gliomas due to restricted movement of water 
molecules. Thus the signal intensity in these regions is high. Areas of necrosis display 
higher ADC values than tumor regions. This is due to the fact that necrosis contains dead 
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 tissue and hence may offer less impedance to water movement than viable tumor. The 
ADC values may help in delineating tumor tissue types.  However, ADC values alone 
cannot be used to differentiate tumors from edema but may be used to make a differential 
diagnosis along with other clinical imaging techniques. 
 
Perfusion - Weighted Imaging (PWI) 
Perfusion imaging measures the rate of delivery of a given quantity of blood to a 
particular region of interest.  Perfusion imaging involves the measurement of 
microvascular parameters like Cerebral Blood Flow (CBF), Cerebral Blood Volume 
(CBV) and Mean Transit Time (MTT).  This technique is particularly useful in the 
noninvasive assessment of brain tumors. Imaging is performed using either exogenous or 
endogenous contrast agents. By measuring the concentration of a tracer agent in the 
region of interest and measuring the arterial input function, tissue perfusion can be 
determined. Gadolinium Diethylene-Triamine Pentaacetic Acid (Gd-DTPA) is the most 
commonly used intravenous exogenous contrast agent in MRI. Gadolinium (Gd) is a 
metal ion with seven unpaired electrons which produce a large magnetic moment. The 
unpaired electrons cause faster relaxation of magnetization. Since the T1 of the local 
water protons reduces as gadolinium is injected into the human body, the signal in T1-
weighted images is increased17. The contrast agent Gd-DTPA cannot cross the blood 
brain barrier in normal brain and hence there is little relaxation effect and in the first pass 
it behaves as an intravascular agent. The change in the T1 relaxation rate is much larger 
than that of T2 and hence they are commonly known as T1 agents. When a GRE sequence 
is used, a T2* signal loss occurs. This is due to the fact that the high magnetic moment of 
the gadolinium causes changes in the susceptibility of the blood as compared to the 
surrounding tissue18. The signal loss due to gadolinium is because the inhomogeneous 
field created additional dephasing of the spins, hence reducing the T2* signal. Spin echo 
imaging can also be used, but it is more sensitive to the changes in the capillaries than the 
larger blood vessels. The signal changes can be used to quantify the local concentration 
of gadolinium by tracer kinetics principles. The application of tracer kinetics principles 
involves obtaining the concentration curve as the first passage of the bolus (Gd-DTPA) 
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 into the tissue takes place.  Quantification can be achieved if the arterial input function is 
measured or modeled19.   
 
Imaging Using Perfusion Techniques 
In our institution, MR contrast agent (Gd-DTPA) is administered at a rate of 5cc/sec for 
20 seconds through a power injector. As soon as the contrast Gd-DTPA is administered, 
the tissue enhancement can be seen within 1 minute. The images obtained are then used 
to generate the relaxivity (the inverse of the relaxation time) versus time curves 
( . ∗∆ 2R = ∗∆ 2T/1 )
∗∆ 2R = - ln [S (t) / S0 ] / echo time                                      (2.3) 
Where S (t), S0:  signal intensities at time t and baseline.   
 
Cerebral Blood Volume 
Cerebral blood volume is defined as the total volume of blood in given region of interest 
and is measured in units of milliliters of blood per 100grams of tissue (ml/100g)20. The 
relative cerebral blood volume (rCBV) maps are obtained by fitting a gamma variate 
function to the relaxivity transit curve for each pixel. The rCBV is calculated as: *2R∆
∫
∞
∆=
0
2 dt)t(RrCBV   (2.4) 
It is independent of the shape of the time course response. The rCBV has arbitrary units 
and is generally normalized to another tissue hence expressed as % of the control region. 
Figure 2.2 shows schematically the procedure to obtain an rCBV map.  
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Figure 2.2 Methodology for perfusion imaging21. 
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Mean Transit Time 
Mean transit time is defined as the average of the transit time of blood through a given 
brain region, integrated across the different paths. The transit time through brain tissues 
is usually about 4 seconds. Practically it is difficult to measure MTT because the bolus 
injection may not be instantaneous. The relative mean transit time (rMTT) is obtained as 
the normalized first moment of the gamma variate fitted curve, up to the peak of the 
curve expressed in units of seconds.   
∫
∫
∆
∆
=
∗
tpeak
0
2
tpeak
0
2
dt)t(R
dt)t(Rt
rMTT   (2.5) 
 
Cerebral Blood Flow 
Cerebral blood flow is defined as the volume of blood flowing through a given brain 
region per unit time. The CBF is measured in units of milliliters of blood per 100g of 
brain tissue per minute (mL/100 g/min). Normally CBF is 60 ml/100g brain tissue/min.  
As the Gd-DTPA contrast passes through larger blood vessels and diffuses into the 
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 surrounding tissues, the changes obtained can be used to calculate the relative CBF 
(rCBV) maps using the central volume theorem as: 
rMTT/rCBVrCBF =  (2.6) 
rCBV is expressed in arbitrary units.  
 
Perfusion Imaging Of Brain Tumors 
Perfusion imaging can be an indicator of tumor angiogenesis which is associated with 
tumor growth. Perfusion imaging has been very useful in stereotactic biopsy guidance, 
differentiating necrosis from tumor. Relative CBV values only reflect the degree of 
vascularity and do not provide a direct measurement of blood volume. It has been shown 
that with histological confirmation, higher rCBV values indicate higher grade tumor and 
higher mitotic activity22. Low grade tumors which have low CBV demonstrated less 
contrast enhancement in tumor regions when compared to high grade tumors22.  
 
MR Spectroscopy Imaging 
Chemical Shift 
The difference between the resonant frequency of a nucleus and a standard, relative to the 
standard is known as chemical shift. Both water and fat in the human body contain 
hydrogen. The chemical shift difference between these two types of hydrogen containing 
substances is approximately 3.5 ppm. The concentration of most metabolites present in 
the human body is typically orders of magnitude less than that of the water or fat signal 
in tissues.  
 
Spectroscopy Imaging 
Spectroscopic imaging provides information about the tissue metabolite concentrations in 
a region of interest. Also known as chemical shift imaging (CSI), this method produces 
an image from one chemical shift component in a region of interest after suppression of 
water and/or fat. Spectroscopic information over multiple regions is processed to create 
maps of the metabolite concentration. In order to obtain the spectroscopic information, 
suppression techniques are used to eliminate the larger water signal and a spectral 
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 dimension is added to the usual MR procedure. The gradients through their range of 
values are used to record the spectra from all points in the spatial-spatial domain. The 
spectra obtained are presented as a series of peaks based on the chemical shift relative to 
a standard (tetramethyl silanie). The peaks obtained in normal brain23 are: N - acetyl 
aspartate (NAA) at 2.0 ppm, choline at 3.2ppm, creatine at 3.0 ppm, and other minor 
peaks are obtained between 2.0-2.2 ppm. The NAA is an indicator of neuronal activity in 
the brain. Creatine is thought to be an indicator of energy, choline, a neurotransmitter, 
appears to be an indicator of membrane turnover 23.  Since the T1 and T2 are related to 
each peak, the height of the peaks obtained depend on the parameters chosen for TE and 
TR. Additional peaks are thus obtained at short echo times as seen in Figure 2.3.  The 
concentration of the metabolites is proportional to the area under the peak for each 
metabolite after correction for T1 and T2 decay.  
 
Spectroscopy Imaging Of Brain Tumors 
Many studies have indicated the potential of spectroscopic imaging in diagnosing brain 
tumors24. Comparison of relative peak heights may be used to indicate abnormalities in 
the brain. Studies have shown that brain tumors have elevated choline, decreased NAA, 
and decreased creatine peaks25. Decreased NAA levels in brain tumors indicate the lack 
of neurons (neuronal death) in glial neoplasm. Choline signal was found to be highly 
elevated in grade II and grade III tumors. High grade glioblastomas demonstrate a low 
creatine peak and in addition to these peaks, a lipid peak at 0.9-1.2ppm and a lactate peak 
at 1.3 ppm. One such set of spectra comparing normal tissue to tumor tissue is shown in 
Figure 2.3 and Figure 2.4. In Figure 2.3, left image shows the T2-weighted image of a 
tumor patient and right image is the spectrum under the square voxel. The square voxel is 
chosen in a normal tissue region so the spectrum of metabolites obtained should have 
increased NAA, decreased choline, and increased creatine peak as seen below. When the 
voxel is chosen in the tumor tissue region in Figure 2.4, the spectrum of the metabolites 
is seen as described for tumors above.  
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Figure 2.3 Spectroscopic image of tumor patient with voxel at normal tissue and its 
spectrum. 
 
Figure 2.4 Spectroscopic image of tumor patient with voxel at tumor tissue and its 
spectrum. 
 
Segmentation Using Fuzzy C - Means Clustering Algorithm 
Segmentation is the process of dividing an image into meaningful regions. MR image 
segmentation of brain or regions of interest can be used to extract different tissues. 
Segmentation in MR images may help in providing better visualization and good 
separation between tissues especially the tumor regions. In segmentation techniques, both 
supervised and unsupervised classification algorithms have been applied to MRI 26.   
 
Supervised and seeding techniques require human intervention. An operator familiar with 
human anatomy is required to outline the regions containing gray matter, white matter, 
etc., and assign a physical label (color) to that region. Then the algorithm is trained and 
data is segmented. Since the anatomical structures differ for each subject this process is 
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 usually time consuming and difficult. The results produced by this method may vary with 
operators and hence may not be reliable and reproducible. Only trained operators may be 
able to use this method which is one of the disadvantages. But since the algorithm is 
trained and then data is segmented they may yield better results where operator 
intervention errors and time can be compromised.  
  
In the unsupervised approaches, the operator is required to assign tissue class labels to 
the colored segmented image data sets and not the original MRI data sets. Unsupervised 
segmentation methods are usually fast and do not require operator intervention to 
segment images hence reducing inter-user variability. Unsupervised algorithms are 
usually based on clustering algorithms and can be easily extended to multidimensional 
data sets. The fuzzy c-means (FCM) algorithm is a type of clustering algorithm that can 
perform segmentation on MR images based on pixel classification method. This may 
yield better results and provide better distinction between anatomical tissues than other 
unsupervised methods. 
 
In this thesis, a software tool is developed for applying unsupervised FCM clustering 
algorithm to a combination of whole volume MRI data sets taken on normal subjects and 
patients with tumors. The results are then compared with the available software SPM227. 
Most of the previous work using FCM segmentation on MRI images28-30 has not included 
any “physiological” data sets (DWI, perfusion, and gadolinium-enhanced images).  
 
Clustering is an unsupervised image segmentation technique that divides the given data 
set into clusters (classes). This division puts similar data objects in the same cluster 
whereas dissimilar data objects belong to other clusters. That is, “N” data samples are 
classified into “n” clusters. An important component of a clustering algorithm is the 
distance measure between data points. A Euclidean distance metric is used to group 
similar or dissimilar data points. Cluster analysis contains a group of different algorithms 
for classifying the data. These algorithms are based on the similarity measure. 
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 Some of the clustering techniques are: 
• Exclusive clustering - Each data point assigned to only one cluster. 
• Overlapping clustering - Each data point can be assigned to one or more clusters. 
Fuzzy c- means algorithm is a type of overlapping clustering method.  
• Hierarchical clustering - Each data point is partitioned in several steps into finer 
classes using a set of fuzzy rules. 
• Probabilistic clustering - For each data point, a probability distribution over the 
clusters is determined from which the probability of belonging to a cluster is 
determined.  
• Objective function based clustering - Most of the clustering algorithms except 
hierarchical, involves minimizing the performance index “J”. Using the sum of the 
squared distances, the optimum value is obtained through iteration. The sum of the 
squared distances signifies the performance index.   
 
The fuzzy c-means (FCM) algorithm was established by J. Bezdek and Dunn in 198131.  
This algorithm is widely used in variety of pattern recognition and medical image 
segmentation applications today32,33. FCM is a fuzzy serial, soft segmentation 
unsupervised pixel classification clustering algorithm. In this algorithm, each data point 
may belong to more than one class through partial memberships. A membership function 
specifies the degree to which a data point (pixel intensity) belongs to a cluster and the 
membership value is the value or the degree of similarity to a cluster. The application of 
fuzzy sets in classifying MRI data sets causes the class membership to become relative, 
since an object can belong to several classes at the same time but with different degrees. 
Previous studies have shown that as the dimension of feature space (multispectral) 
increases, MRI image segmentation improves 34,35.  
 
The FCM algorithm uses an iterative approach which minimizes the objective function, J 
the sum of weighted distances (Euclidean distance) between each data point, and the 
cluster center, and searches for compact clusters. All clusters calculated are 
approximately the same size and each of them is represented by their centers. 
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Where, 
J - Objective function, 
uij  - Membership matrix - contains all the membership values for each data point xi in 
class j, 
cj - c = (c1, c2,….,cj) - Vector of cluster centers where cj – cluster center of class j,  
C - the number of classes for 1≤ j≤C, 
xi - ith of d-dimensional data,  
m - Weighting exponent of each membership, 
|| * || is any norm between any measured data and the center. 
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The iteration stops if ε<−− )1i(J)i(J , where ε >0. 
 
The membership matrix uij contains the membership degree values between [0,1] where 1 
represents that the data point xi belongs to a cluster j and a value of 0 represents that the 
data point does not belong to the cluster j.   
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 An optimal number of classes must be chosen in order to obtain good segmentation 
results.  In this application, the number of classes represents the number of brain tissue 
types. The FCM algorithm clusters the data set into the number of classes specified. If 
more classes are specified it may result in over-segmentation in the case of normal 
tissues. But in case of abnormal tissues like tumor, more classes may be required to be 
specified. Hence it is important to know the number of tissue types to be classified. To 
understand our data set better, the FCM algorithm has been used with different number of 
classes and compared to find the best possible class number. A cluster center plot of the 
data set may be helpful in deciding the number of classes. Such a cluster center plot is 
shown in Figure 2.5. 
Figure 2.5 3D Cluster center plot with four classes of a simulation dataset. 
 
Another important parameter is the exponent ‘m’ which is the degree of fuzziness. For 
each iteration of the calculation of the objective function, the degree of fuzziness ‘m’ 
needs to be specified. The parameter m controls the slope of U thus determining the 
quantity of class overlapping. The degree of fuzziness m can be any value greater than 1 
for the FCM algorithm. As m increases, the membership function U decreases as seen 
from Equation 2.5. It has been shown that the greater the m, the fuzzier (greater the 
overlap) the results36. By decreasing the value of m (closer to 1) we can obtain crisp 
membership indicator functions. The different types of membership indicator functions 
for different m values are shown in Figure 2.6. 
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 m = 1.5      m = 2.0 
Figure 2.6 Membership functions with respect to m 37. 
 
Keeping in mind the above parameters, the ideal number of classes and degree of 
fuzziness m for both normal and abnormal subjects were chosen in our algorithm. The 
iterative process J is minimized when high membership values (uij) are assigned to pixels 
whose intensities are closer to the particular cluster centroid and low membership values 
are assigned to pixels whose intensities are far from the cluster centroid.  
 
The segmented data are then labeled by class (tissue type). At this stage, the pixels are 
color-coded to differentiate between tissue types. The process called defuzzification uses 
the maximum membership rule. The maximum value of uij is chosen and if it is greater 
than a threshold value, the pixels containing those membership values are coded a color 
(segmented into a class). The plot in Figure 2.7 represents a membership matrix u with 
threshold of 0.55 for a one-dimensional data set. 
 
Figure 2.7 Membership function indicating threshold value of 0.55. 
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 Chapter 3  
 
Methods 
Simulation Models 
Before pre-processing and segmenting the real MRI data sets, in order to understand our 
data three types of simulation models were created. They are: 
• Simulation using stripes -  7 tissue types 
• Partial volume simulation -  3 tissue types 
• Brain Region-of-Interest (Brain ROI) - 3 tissue types. 
 
Simulation Using Stripes 
The intensity values of a normal brain of seven different tissue types were measured for 
T1, T2 and FLAIR images. Using these values an 8 stripe matrix was created. This image 
contained eight tissue types and eight pixels per tissue stripe.  Figure 3.1 shows a 
simulations stripe containing such T1, T2, FLAIR image intensities.  
T1    T2     FLAIR  
Air, Air, Scalp, Skull, Meninges, Gray Matter, White Matter, CSF 
Figure 3.1 Simulation of intensity using stripes 
 
Table 3 shows the values for each tissue type. 
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 Table 3: Pixel intensity values for simulation 
Tissue T1 T2 FLAIR 
Air 40 10 10 
Scalp 740 550 330 
Skull 80 40 20 
Meninges 380 220 130 
Grey Matter 370 480 140 
White Matter 570 400 90 
CSF 350 1530 50 
 
Using FCM, MATLAB38 scripts were written to segment these stripes. A standard color 
map was developed and each tissue type was assigned a color. The color map can 
accommodate up to 12 classes (tissues) presently and is shown in Figure 3.2. In this work 
only six classes (colors) for normal and nine classes (colors) for patients with tumors 
were used.  
 
 Unclassified Class 1 Class 2 Class 3 Class 4 Class 5 Class 6 Class 7 Class 8 Class 9 Class 10 Class 11
Figure 3.2 Color map 
 
In MR images, thermal noise is the primary source of random noise and is characterized 
by a Rician noise but can be approximated by Gaussian distribution. Hence we add 
randomly generated white Gaussian noise to each intensity value in order to simulate 
noise in the MRI data.  The stripes are then segmented using the FCM algorithm in 
MATLAB. Since each stripe is a tissue (class) perfect segmentation should result in 
stripes only. The simulation stripes were segmented with and without intensity 
normalization. In intensity normalization, the intensity values were scaled to the 
maximum value. The centers calculated from FCM and their membership values were 
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 plotted and examined for this optimization. The norms of the centers were also calculated 
and sorted to identify tissue types. The number of inconsistent classifications (incorrect) 
were calculated as percentage error for each run of FCM and plotted versus threshold for 
noise levels from 10 increasing to 40. The simulation stripes are segmented with different 
number of classes, noise levels, exponent m and thresholds for selecting of the optimal 
parameters for these types of images.  
 
Partial Volume Simulation 
A partial volume effect in a MR image means voxels may contain a mixture of tissue 
types.  The partial volume effects can be decreased by decreasing the voxel size in a MR 
image. Shown below in Figure 3.3 a) is an image with 1 x 1 x 1 mm3 slice. This image 
when the resolution is increased to 2 x 2 x 2 mm3 as in Figure 3.3 b) displays partial 
volume effects.  
 
Figure 3.3 Partial volume effects - a) 1 x 1 x 1 mm3 image  b) 2 x 2 x 2 mm3 image 
showing partial volume blurring. 
 
In order to see how partial volume affects FCM segmentation, partial volume stripes 
were created for only three types of tissue (gray matter, white matter, CSF).  The stripe 
model is shown below. 
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The simulation model was run for different values of exponent m, noise levels and 
thresholds. The number of classes was specified as only three since it contained only 
three tissue types.  
Avg. Avg. Avg. GM GM GM GM WM WM WM WM CSF CSF CSF CSF GM GM GM GM
 
Brain Region-of-Interest Simulation 
Next, to check in a real data set how FCM segmentation works, a region of interest (ROI) 
was selected from the obtained MR images of normal subjects. The ROI was chosen in 
such a way that it contained only the GM, WM, CSF tissues from the middle of the MR 
brain image. Figure 3.4 shows a brain ROI of a normal subject. 
FLAIR    SPGR    T2 
 
 
 
 
 
 
 
Figure 3.4 Brain ROI 
 
The FCM was then run for this model to see the segmentation results in actual data. Here 
also the FCM was executed for different values of exponent m and thresholds. The 
number of class was fixed at three since there are only three tissue types. The optimized 
values of m and threshold from all these simulations were used to segment the actual data 
sets.   
 
MRI Volume Data Sets 
In this thesis, the FCM clustering approach was applied to multispectral MRI (T2, 
FLAIR, SPGR-pre contrast, SPGR-post contrast, SPGR-post contrast (SPGRGd), DWI) 
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 image data sets which segmented them into different tissue types including abnormal 
tissues. So for each pixel i, the feature vector was comprised of xi = [T2i, Fli, DWIi, Spgri, 
SpgrGdi]. By adding more image types (multi spectral) the segmentation may improve 
and provide more information 39. The feature vector xi is a five-dimensional vector. The 
feature vectors were then segmented into six classes for normal tissues and nine classes 
for abnormal tissues. The m value used on these data sets was set to m = 1.5. The 
optimized threshold value from the simulation data sets = 0.55 was used for classifying 
into clusters (tissues). These values were chosen as the best values to include pixels while 
not mixing classes after inspecting the cluster vector plots and membership function 
plots.  The tissue classes which look like white matter, gray matter and CSF were 
compared to white matter, gray matter and CSF segmented images from Statistical 
Parametric Mapping software27 (SPM2).  
 
Data Acquisition and Analysis 
Using all the imaging procedures mentioned in Chapter 2, MRI scans were obtained in 
four normal subjects and five tumor patients. Table 4 below shows the type of tumor for 
each tumor patient. All tumor patients have undergone radiation therapy, chemotherapy 
and / or surgery. 
Table 4: Tumor types in patient sample. 
Patient Tumor type 
Patient 1 Grade IV Glioblastoma Multiforme 
Patient 2 Grade II Gemistocytic Astrocytoma 
Patient 3 Astrocytoma 
Patient 4 Grade II Gemistocytic Astrocytoma 
Patient 5 Low grade Astrocytoma 
 
The types of MRI scan taken for each subject, and the parameters involved are 
summarized in Table 5. The total scan time was around 1 hour and 15 minutes.  
• Anatomical scans were taken first (3-Plane Localizer, DWI, FLAIR, and T2). 
• Next, pre-contrast high resolution images (3D SPGR) are obtained.  
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 • Intravenous contrast Gd-DTPA (20ml) is injected through a power injector. During 
the first passage of the bolus, perfusion scans are obtained.  
• A high resolution (3D SPGRGD) post contrast scan is then obtained.  
• Last, a T1 (GD) contrast enhanced image is obtained. 
Table 5: Imaging Parameters 
 
Series 
Name 
(view) 
Field-of-
view(FOV) 
(mm) 
 
# 
Slices 
Slice 
thickness
(mm) 
TR 
(ms) 
TE 
(ms) 
TI 
(ms) 
Matrix 
Freq*phase
Loc(Sag) 25 14 5 10,000 73 - 128*128 
DWI(Ax) 25 14 5 10,000 73 - 128*128 
FLAIR(Ax) 25 14 5 11,000 170 2250 256*192 
T2(Ax) 25 14 5 5,000 102 - 256*256 
3D 
SPGR(Ax) 
25 14 5 7.5 7.5 - 256*192 
Perf(EPI) 25 14 5 2000 20 - 128*128 
3D 
SPGRGD(Ax) 
25 14 5 7.5 7.5 - 256*192 
T1GD(Ax) 25 14 5 750 7.5 - 256*224 
The obtained images were preprocessed before segmentation. The images were first 
converted into 3D datasets using Analyses of Functional Neuroimages (AFNI) 
software40. Since structure of the human brain varies across subjects, the first step for 
each subject was to align individual MR image scans. The subjects head position may not 
be in the same location during each and every scan taken. Also, image distortion varies 
from pulse sequence to pulse sequence.  
 
Most brain atlases are based on a detailed representation of anatomy in a standardized 3D 
coordinate system, or stereotaxic space. Anatomical points are chosen on high resolution 
(2mm3) 3D anatomical data sets. Anatomical markers help in transforming the MR data 
 35
 sets to stereotaxic space. The stereotaxic coordinate system 41 is defined as below: 
The anatomical landmarks are:  
• Anterior commissure (AC) – It is a thin white matter tract connecting each 
hemisphere near the olfactory areas of the brain. 
• Posterior commissure (PC) – It is a C-shaped structure slightly rotated in a clock-wise 
direction located posterior and inferior to the AC also connects the hemispheres. 
There are two nerve fibers connecting the cerebral hemispheres across the longitudinal 
fissure as shown in Figure 3.5.  
• The anterior-to-posterior horizontal axis (y) is the tangent to the superior edge of the 
AC and to the inferior edge of the PC, at points crossing the longitudinal fissure.  
• The vertical axis (z) is perpendicular to the AC–PC line, in the longitudinal fissure, 
and the tangent to the posterior edge of the AC.  
• The remaining axis (right-to-left or x) is perpendicular to the y and z axes.  
 
Figure 3.5 Sketch of the central portion of the midline of the brain showing anatomical 
landmarks used to specify the stereotaxic coordinate system. 
 
The transformation to the AC–PC-aligned view was made by placing ‘‘markers’’ as 
shown in Figure 3.5 on: 
• The superior and posterior edges of the AC. 
• The inferior edge of the PC. 
• Given the AC–PC line (the new y-axis), one point in the new yz plane. 
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 • Two points (separated by at least 20 mm).  
After choosing anatomical landmarks, the whole brain volume was rotated to align with 
the stereotaxic axes. This aligned, not scaled, coordinate system data set is called the 
AC–PC aligned view. The aligned datasets are then resampled into 1 x 1 x 1 mm3 
resolution in the slice select direction between input slices using cubic interpolation. The 
aligned data sets were written out as ACPC aligned volumes along with a header file.  
 
Another method for co-registering the data sets of the same subject is using rigid body 
transformation in SPM2 software42. SPM contains a list of subroutines based on 
MATLAB. Rigid body transformation is a subset of the affine transformations. Affine 
transformation is described by six parameters, three translational and three rotations 
along the orthogonal axes. For each point in an image (x1, x2, x3), an affine mapping is 
defined into the co-ordinates of another space (y1, y2, y3). The mapping is described as a 
simple matrix multiplication: 
 y = Mx  (3.1) 
Where, x – matrix containing values of an image, 
y – matrix containing co-ordinates of another space for the corresponding values of x, 
M - matrix containing mapping values. 
 
Using SPM2 software to co-register the images, an affine transformation was applied in 
which one of the images was considered as a reference image (the target image usually 
SPGR image). Another image was transformed (mapped) to match the co-ordinates of the 
target image. The images are then resampled based on the transformations by trilinear 
interpolation method. The voxel dimensions are resampled to the SPGR image voxel 
size. Hence, each image type (T1, T2, FLAIR etc.) are mapped to the SPGR image using 
an affine transformation.  The images are then spatially normalized where each subject’s 
image is mapped to a standard space.  This allows for averaging of data and comparison 
between subjects. The normalization is usually done by spatially transforming the images 
to a template image in standard space. The sum of the squared differences between the 
template image and the image is minimized or the correlation between the images is 
maximized. Spatial normalization can also be carried out using affine transformation. 
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 This transformation uses a 12 parameter rigid body nonlinear transformation to map the 
image to a template. The intensity of the images may be scaled and smoothed to a certain 
extent in this method.   
 
Next, the high resolution SPGR images are segmented into gray matter (GM), white 
matter (WM) and Cerebrospinal fluid (CSF). The segmentation using SPM is based on 
the maximum likelihood mixture model clustering algorithm. It utilizes a priori 
probability images of GM, WM, and CSF 43. This model assumes that MR images 
contain a certain number of tissue types from which every voxel has been drawn. 
Through spatial transformation each voxel from the high resolution images was mapped 
to the corresponding location in the a priori probability images. The mapping was 
achieved by least squares matching the template images in the same standard space. 
Estimating which voxel belongs to which tissue type requires an iteration process. The 
iterative process ends when the change in log-likelihood function is negligible. The 
algorithm is also known as the expectation maximation (EM) algorithm 43. The E-step 
denotes the calculation of probabilities of belonging to a cluster and the M-step computes 
the clusters and non-uniformity correction parameters. For the calculation of probabilities 
belonging to a cluster, Bayes rule44 is used. For non-uniformity correction parameters, 
discrete cosine transform is utilized. SPM fails when patient data are analyzed as there 
are no prior probability images that can be used as a template image. 
 
In order for the segmentation to start, the AFNI data sets were first converted to 
ANALYZE format for compatible use in SPM2 where by the AFNI data sets were 
converted to “.img” format along with a header file. All the images were co-registered, 
spatially normalized and resampled to 1x1x1 mm3 resolution. The “.img” files were then 
read into a MATLAB script for performing fuzzy c-means segmentation of tissue types. 
Similarly, using SPM2 software, the high resolution SPGR images alone were segmented 
into the three tissue types (GM, WM, and CSF). The segmentation results using fuzzy c-
means clustering were then compared to the segmentation results using SPM2.  
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 Chapter 4  
 
Results 
Simulation Using Stripes 
The FCM MATLAB code was executed for the simulation of stripes which contained 
seven tissue types. The stripe model shown below contains T1, T2, FLAIR intensity 
values with no noise. 
T1 T2  FLAIR 
Figure 4.1 Simulation stripes of seven tissues with three types of images. 
 
The eight tissues in Figure 4.1 are:  air, air, scalp, skull, meninges, gray matter, white 
matter, CSF. The air tissue is repeated twice in order to form an 8 x 8 stripe. The number 
of classes was chosen as seven for FCM segmentation and they were executed for m 
values of 1.05, 1.25, 1.5, 1.75, 2.0, noise levels of 0, 10, 20 (arbitrary units) and threshold 
values of 0.55, 0.75, 0.95. Since the number of classes was seven, each class (tissue) is 
assigned a color from the color map. The color map designed is shown below: 
 
  
 
Unclassified Class 1 Class 2 Class 3 Class 4 Class 5 Class 6 Class 7
 
 
 
 
Figure 4.2 Color map used for normal subjects. 
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 Cluster center plots: 
The segmentation was carried out for feature vectors composed of pixels from T1, T2 and 
FLAIR images. The cluster centers in 3-D space of the respective classes are plotted for 
each feature vector. The plots help in determining the number of classes (tissues) to be 
used. Shown below is a cluster center plot for m = 2.0, threshold = 0.55.   
Figure 4.3 Cluster center plots a) Clusters = 4 b) Cluster = 7 
 
Figure 4.3 shows the difference in cluster centers when we segment the data into cluster 
= 4 and cluster = 7. Note that when we group them into a larger number of clusters the 
centers are closer to each other thereby segmenting the data differently. Also, since the 
intensity values of air and scalp are close to each other, their respective cluster centers in 
Figure 4.3 b close to the origin can be seen to be redundant.   
 
Membership degree plots:  
During the iteration of the algorithm, the membership value are determined and updated. 
The membership values for each class were plotted. These plots help in determining the 
m (fuzziness) for the data set and also in setting the threshold.  The membership values 
for m = 1.25 for two different classes are shown in Figure 4.4. 
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X-axis pixel intensity values   X-axis pixel intensity values 
Figure 4.4 Membership value plots a) class - 4  b) class - 6 
 
Figure 4.4a shows that the membership degrees range between 0 and 1 for the pixel 
intensities from 35 – 55. Figure 4.4b shows that in the range of 35-55 pixel intensities the 
membership degree is zero. This indicates that pixel values in that range do not belong to 
cluster 4.  The membership value plots for m = 2.0 is shown below. 
Y
-a
xi
s m
em
be
rs
hi
p 
va
lu
es
 
Y
-a
xi
s m
em
be
rs
hi
p 
va
lu
es
 
X-axis pixel intensity values X-axis pixel intensity values 
Figure 4.5 Membership value plots a) class - 4  b) class - 6 
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 The membership values for the same pixel range as in Figure 4.4 for the class 6 is zero in 
Figure 4.5. Using these plots the m value was fixed at 1.5 with number of classes = 7.  
 
Threshold value: 
The threshold value determines which pixels belong to a particular (class) based on its 
maximum membership value. Since each stripe is a tissue, perfect segmentation should 
result in each color stripe only. The tissue class containing a mixture of colors may 
represent that the tissue class may contain two or more tissues.  The simulated segmented 
images of T1, T2, and FLAIR for noise = 0, m=1.5, threshold = 0.55 are shown below in 
Figure 4.6. 
 
 
 
 
 
 
 
a) Threshold value =0.55  b) Threshold value = 0.75 c) Threshold value = 0.95  
Figure 4.6 FCM simulated images for noise = 0. 
The differences in threshold values for a fully segmented and mixed segmentation class 
are shown below in Figure 4.7.  
0.55 0.55 
a) Pure segmentation class 4   b) mixed segmentation class 4 
Figure 4.7 Membership value plot showing threshold = 0.55. 
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 From Figure 4.6 and 4.7 it can be seen that as the values of threshold increases mixed 
segmentation results. In the case where threshold value is less than 0.55, again mixed 
segmentation was obtained. Hence for our data set an optimized threshold value of 0.55 
was chosen. The simulated segmented images of T1, T2, and FLAIR for noise = 10, 
m=1.5, threshold = 0.55 are shown in Figure 4.8. 
 
a) Threshold value =0.55  b) Threshold value = 0.75 c) Threshold value = 0.95  
Figure 4.8 FCM simulated images for noise =10. 
 
Partial Volume Stripes  
As described in chapter 3, a partial volume stripe is created for the three feature vector         
(T1, T2, and FLAIR) as shown in Figure 4.9.  
 
 
 
 
 
 
 
T1     T2    FLAIR 
Figure 4.9 Partial volume simulation stripe. 
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 These simulation stripes were executed for m values in the range of ima and a threshold 
value of 0.55, 0.75 and 0.95 with different noise levels. Figure 4.10 is a FCM segmented 
simulation stripe with different threshold values for an m =1.5. 
 
a) Threshold = 0.55   b) Threshold = 0.75  c) Threshold = 0.95 
 
 
 
 
Avg. Avg. Avg. GM GM GM GM WM WM WM WM CSF CSF CSF CSF GM GM GM GM
Figure 4.10 FCM segmented images for partial volume simulation. 
The red pixels in Figure 4.10 c) indicate unclassified tissue type. In Figure 4.10 a) the 
pixel stripe containing a mixture of white matter and CSF is classified as gray matter. 
The stripes may indicate more weighting to white matter. The cluster centers and 
membership degrees are also plotted for this simulation stripe.   
 
Classification error: 
The cluster plots and membership degrees for both types of simulation stripes change for 
different threshold values for different noise levels.  The percentage error of misclassified 
pixels is calculated as: 
(Number of incorrect pixels / Total number of pixels) x 100 
These values help in determining the range of m values and threshold values that can be 
used for segmenting our MRI data set.   
 
Brain ROI Simulation Model 
A region of interest was selected from the normal subject’s MRI data set as described in 
chapter 3. The region of interest contained only three types of tissue – GM, WM, CSF. 
The image vectors included were FLAIR, T2, SPGR and FCM algorithm is executed for 
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 class = 3 for the ROI alone. The image inputs to FCM are shown in Figure 4.11.  
 FLAIR    SPGR    T2
 
 
 
 
 
 
 
Figure 4.11 Brain ROI of three image vectors 
 
The FCM was executed for different m values and thresholds of 0.55, 0.75 and 0.95.  The 
FCM segmented image for m = 1.5 is shown below in Figure 4.12. 
 
 
 
 
 
 
 
a) Threshold = 0.55   b) Threshold = 0.75  c) Threshold = 0.95 
Figure 4.12 FCM segmented Brain ROI, Green: Gray Matter; Black: White matter; 
White: CSF, Red: unclassified. 
 
Comparing Figure 4.12 a) segmented image to the original images, the segmentation is 
good. Though there might be some more weighing towards white matter consistent with 
the partial volume stripe model. From the above images it is seen that as the threshold 
value increases the number of unclassified pixels increases. Hence for our data set, m = 
1.5 with threshold = 0.55 is chosen as the optimal value for MR whole volume data sets.  
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 MRI Data Sets  
The whole volume MRI data sets are then segmented using FCM for each subject. The 
optimal values are fixed at m = 1.5, threshold = 0.55.  Figure 4.13 shows the FCM 
segmented image for a normal subject for feature vectors (FLAIR, T2, SPGR pre and post 
contrast, DWI). The feature vector is segmented into six tissue types for normals and nine 
tissue types for patients with tumor. Different colors from the color map represent 
different tissue types. The FCM segmented image when another feature vector DWI is 
added is also shown in Figure 4.13.  
 FLAIR SPGR T2 
 
 SPGR-GD FCM image FCM image with DWI 
 
Figure 4.13 FCM segmentation of normal subject. 
The class representing gray matter (GM), white matter (WM), and CSF are extracted 
from the single colored image and displayed separately in Figure 4.14 a).  GM, WM, CSF 
maps are obtained from the standard SPM software and displayed in Figure 4.14 b). FCM 
images are subtracted from the SPM maps and the difference maps are displayed in 
Figure 4.14 c).  
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 a) FCM: Gray Matter White Matter  CSF 
 
 b) SPM: Gray Matter White Matter  CSF 
 
c) Difference image: Gray Matter White Matter  CSF 
Figure 4.14 Difference maps of normal subject 
 
For a tumor patient, as seen in Figure 4.15 the feature vector (FLAIR, T2, SPGR, 
SPGRGD, DWI) is segmented into nine tissue types. This is done in order to include the 
tumor tissues, edema and necrosis.  Figure 4.15 also shows the FCM segmented image of 
tumor subject with the addition of DWI to the feature vector. 
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 FLAIR    SPGR    T2 
 
SPGR-GD    FCM image  FCM image with DWI 
 
Figure 4.15 FCM segmentation of tumor patient. 
 
The class representing gray matter (GM), white matter (WM), and CSF for tumor subject 
are extracted from the single colored image and displayed separately in Figure 4.16 a).  
GM, WM, CSF maps are obtained from the standard SPM software and displayed in 
Figure 4.16 b). FCM images are subtracted from the SPM maps and the difference maps 
are displayed in Figure 4.16 c).  The results for all the subjects are shown in Appendix A. 
The percentage of difference for the maps are calculated and tabulated in Table 6 and 7 
with and without DWI respectively. 
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a) FCM segmented GM map WM map CSF map 
 
b) SPM segmented GM map WM map CSF map 
 
c) Difference maps GM map WM map CSF map 
Figure 4.16 Difference maps of tumor patient. 
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 Table 6: Quantitative Difference in GM, WM, CSF maps using four feature vectors. 
Gray matter White matter CSF 
Subjects 
FCM      SPM difference FCM SPM difference FCM SPM difference
Normal subj:   
N1 23.54        37.08 24.73 21.51 24.21 11.16 1.90 17.56 15.85
N2          26.36 35.25 15.30 22.79 23.92 4.88 8.37 20.85 14.23
N3          24.18 34.10 16.24 23.20 27.28 7.15 8.55 16.58 13.46
N4          20.85 36.77 17.69 26.77 37.46 11.45 4.28 11.83 16.11
Tumor subj:   
P1 18.50        36.30 24.93 14.73 22.51 14.95 3.66 21.08 17.76
P2          11.46 36.53 29.87 15.51 28.54 25.54 3.40 18.37 15.94
P3          19.07 37.63 24.32 19.73 21.89 11.23 10.70 18.90 22.08
P4          17.59 36.98 23.15 18.32 23.14 11.08 8.34 12.04 16.95
Table 7: Quantitative Difference in GM, WM, CSF maps using five feature vectors. 
 Gray matter White matter CSF 
Subjects  
      
# slices
FCM SPM difference FCM SPM difference FCM SPM difference
Normal 
subj:   
N1           70 21.18 35.48 21.43 20.53 23.85 6.90 10.59 17.92 18.64
N2        55 19.00 35.04 21.62 29.38 23.61 12.34 1.23 20.88 19.76
N3        39 17.31 33.93 21.87 34.23 26.79 15.54 3.83 16.66 15.34
N4        27 20.64 45.67 37.32 32.39 30.71 15.47 1.90 10.41 10.05
Tumor subj:   
P1 63       8.83 36.28 31.64 15.44 27.11 13.14 2.55 20.57 18.39
P2        76 14.04 38.11 37.77 15.36 29.45 24.93 2.06 18.55 17.40
P3        50 14.38 38.31 29.06 23.51 23.41 17.27 2.70 18.91 18.31
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 Chapter 5  
 
Discussion and Conclusions
In this thesis, unsupervised fuzzy clustering was applied to MRI multispectral data (T2, 
FLAIR, SPGR, SPGRGD, DWI) for segmenting two types of images: those from normal 
brain and from brain with brain tumor. Our hypothesis was that using different MRI 
image types instead of the previously used T1-wtd., T2-wtd., and proton density MRI with 
FCM could yield better segmentation results for brain MRI of patients with brain 
tumor(s). We used four-dimensional feature vectors composed of FLAIR, T2-wtd., 
SPGR, and SPGR post Gd-contrast administration.  Each voxel contained data for a 
single pixel from each of the scans.  We also added another dimension to the feature 
vectors by including DWI-MRI. This extension to more and differently composed feature 
vectors has been suggested in previous work39.  
 
To the best of our knowledge, our work is the first whole-brain fully automated multi 
tissue segmentation that has been performed on both normal and patient data sets. The 
inclusion of the whole cerebrum provides more of each tissue type which improved the 
segmentation for the patient data. One drawback of previously published single slice 
segmentation is that it cannot be as automated since each slice may contain different 
numbers of tissue types as the location changes.  All tissue types were always included in 
this FCM processing so the number of classes remains stable. The data sets were checked 
for registration and then resliced to 1mm x 1mm x 1mm voxels for the segmentation. 
These results are not presented here. Having performed the appropriate and necessary 
preprocessing we could then quantify the difference between segmentation by our routine 
and another routine for the gray matter volume, the white matter volume and CSF 
volumes. We compared FCM to another brain segmentation package, SPM227. To our 
knowledge quantification by difference images of this sort has not been presented before. 
 
Our first results indicate that segmentation using the FCM algorithm when tumors are 
present provides the ability to segment normal gray and white matter without including 
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 tumor as part of either.  The commonly used segmentation routines in SPM2 suffer this 
problem as they rely on an underlying model of the brain which does not include any 
abnormalities. All of the brains with tumor were segmented more accurately, as 
compared to the 3D-SPGR with good gray-white matter differentiation, using FCM than 
with SPM2. The FCM always separated the tumors as different tissue types than either 
gray, white, or CSF or even the scalp, skull or meninges. For the normal brains, SPM2 
was the better choice for segmentation as the FCM consistently underestimated the 
amount of gray matter, especially in the medial regions of the brain.  This may be 
because the T2 and FLAIR images used displayed some brightening in the middle caused 
by the dielectric effect seen at 3T which SPM2 seemed to correct in the SPGR data used 
for segmentation in SPM2.  FCM and SPM2 performed more comparably for the 
estimation of white matter and CSF.  Larger voxels, 2mm x 2mm x 2mm were also tried 
to increase FCM processing speed but this decreased the accuracy of the separation into 
classes when the FCM results were compared to the SPM2 results. 
 
It is to be noted that comparison of FCM segmentation tissues (GM, WM, and CSF) with 
SPM2 segmented tissues provides only a method for comparison and not a measurement 
of error because histological data confirming brain tissue types is not available from live 
humans. It is possible that future experiments could include histological staining and 
slicing of an animal brain could be used for such as absolute measurement of tissue type 
accuracy. The FCM to SPM2 segmentation comparison seems to improve with well 
registered data sets but since that is the best case for SPM2, this doesn’t mean that SPM2 
is inherently superior. In the case of tumor subjects the GM, WM, CSF tissues are not 
separated well by SPM2 or FCM.  This may be because the effects of radiation and 
chemotherapy may change the characteristics of normal tissues.  
 
Our work is an extension of previous studies of tissue segmentation using the fuzzy c-
means algorithm on MRI images that showed the promise of this method39. In that study, 
segmented tissues from FCM were compared to histology and postmortem reports.  The 
segmentation was applied to a single slice of the brain through the tumor with T1, T2, 
Proton density images as feature vectors. However, results indicated that this attempt to 
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 classify the tumor cells infiltrating into normal tissues was unsuccessful although the 
edema was successfully segmented from the surrounding tissue.  No work was done to 
determine if the grey matter, white matter, and CSF classes were corrected identified and 
sample error from the biopsy was present in the results.  
 
In other work, FCM segmentation was compared to various other methods. One method 
compared the fuzzy and k-nearest neighbor algorithms32. For both of these algorithms 
knowledge-based techniques were used to improve the segmentation after the clustering. 
Both methods were applied to whole volume MR data sets using the same three mostly 
anatomical image types as in the other study. They used either the fuzzy or k-nearest 
neighbor (kNN) algorithm along with regions described by templates to label and classify 
the tissues after clustering.  However this method was unable to categorize the tissues 
with abnormalities since a prior model of normal brains cannot be used in this case.  
 
In another study45, a semi-supervised FCM (SFCM) algorithm was applied to tumor 
subjects and the results were compared to kNN, gray level thresholding and seed 
growing.  Seed growing methods require manual selection of voxels of interest; such 
methods can be highly operator dependent. Using their SFCM algorithm tumor volumes 
were measured and the values did not consistently match the values from the other 
techniques as measured by the inter- and intra-operator coefficients of variation. 
Moreover, the SFCM was performed on semi-supervised and masked (skull and 
meninges stripped) images so the advantage of automation was reduced.  In this study the 
problem of a gold standard was also mentioned. For human brain tumor segmentation 
only immediately post-mortem scans can be validated without sampling error. Presurgical 
or pre-biopsy scans can be helpful especially if performed under image guidance.   
 
The unsupervised segmentation of MR images using different algorithms has also been 
compared in earlier studies28. The algorithms used in this study were two types of fuzzy 
c-means: one which uses a predefined number of classes and another based on maximum-
entropy which does not. The results demonstrated that each of these methods can 
successfully segment normal brain MR images but they did not attempt to apply either 
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 algorithm to patient data.   
 
An understanding of the fuzzy clustering algorithm is required before applying the 
algorithm to MR data sets. Important parameters like the number of clusters (tissues), m 
(degree of fuzziness), and threshold values of the FCM algorithm need to be considered. 
This technique, when used with a smaller number of classes, resulted in a segmentation 
that merged the tissue types. Moreover as the number of feature vectors or number of 
clusters increases, the FCM algorithm calculation times increase linearly.  The time 
consumed for segmenting approximately 100 slices is about 90 minutes.  An important 
future step for this project is the minimization of processing time by translating the 
MATLAB code into C and reevaluating the algorithm.  That is a large project that could 
take a significant amount of time. 
 
SPM2 is a commonly and popularly used software package to segment brain images.  
SPM2 is based on the maximum-likelihood mixture model clustering algorithm and can 
be performed using just T1-weighted or with multimodal inputs.  In the description of the 
SPM technique27, the segmentation results were verified only by comparison to the input 
T1-wtd., or T2-wtd. images. In order for the tissue segmentation to work well using 
SPM2, good contrast MRI images are a requirement. If the images are not registered 
well, the normalization and hence segmentation of the images using SPM2 is poor as 
seen in Figure A-20. The segmentation accuracy with respect to misregistration of images 
has been found to follow a normal distribution using SPM2 27. Moreover, when voxels 
contain partial volume effects, they are often segmented incorrectly as gray matter 
particularly. Since segmentation is done using a priori probability images, segmenting of 
abnormal tissues will almost always yield poor results. This is a primary limitation of 
SPM2 software is for the segmenting tissues when abnormalities are present. 
 54
 For this project, the MRI data sets did not require co-registration because of patient 
movement or image distortion, the images were co-registered and normalized only in 
order to compare them to the segmentation using SPM2 software. The additional 
advantage of interpolation to a higher spatial resolution also improved the FCM results. 
For some patients, identical slice prescriptions were not possible across the MRI 
modalities, image reslicing allowed us to work around this problem. 
 
In spite of the intuitive sense that adding diffusion-weighted images would improve the 
tissue segmentation, our results indicate that adding DWI to the feature vectors did not 
yield better results for these images as seen in Figure 4.15 and Table 6, Table 7. This may 
be due to the fact that diffusion weighted images may contain distortions.  
 
Another confound was that the dielectric effect generated-inhomogeneities present in the 
more inferior portion of the MRI data sets added a spurious class to the data as seen in 
Figure A-1. This effect caused FCM results for the upper half of the slices to differ from 
the whole brain segmentations. The more superior slices which do not demonstrate this 
effect show good separation of tissues as seen from Figure A-4. In the future the FCM 
segmentation should be applied to images acquired on a 1.5T scanner to test if this effect 
can be removed.  Alternately, intensity smoothing filters could be applied or phased-array 
surface head coils could be used at 3T. 
 
In summary and conclusion, the FCM technique developed for this thesis work can be 
used as for tumor segmentation and in detecting brain tumor region changes along with 
MRI images. The method is better than SPM2 for selecting normal gray and white matter 
in brains that have tumors although not as good as SPM2 for segmentation of normal 
brains.  Future work should include an exploration of the application of this technique to 
1.5T images, application to other types of abnormalities, accuracy determination through 
animal model work, and improvements to speed of processing. 
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 Normal subject (N1): Inputs to FCM (FLAIR, T2, SPGR, SPGRGD) 
 FLAIR SPGR-precontrast T2 
 
SPGR-Gd   FCM image 
 
Figure A-1: MRI volume data sets segmented into six classes (tissue) types. 
 
 FLAIR SPGR-precontrast T2 
 
SPGR-Gd  FCM image 
 
Figure A-2: MRI volume data sets at another slice location segmented into six classes (tissue) types. 
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 Normal subject (N2): Inputs to FCM (FLAIR, T2, SPGR, SPGRGD) 
 FLAIR SPGR-precontrast T2 
 
SPGR-Gd    FCM Image 
 
Figure A-3: MRI volume data sets segmented into six classes (tissue) types. 
 
 FLAIR SPGR-precontrast T2 
 
SPGR-Gd    FCM Image 
 
Figure A-4: MRI volume data sets at another slice location segmented into six classes (tissue) types. 
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 Normal subject (N3): Inputs to FCM (FLAIR, T2, SPGR, SPGRGD) 
 FLAIR SPGR-precontrast T2 
 
SPGR-Gd    FCM Image 
 
Figure A-5: MRI volume data sets segmented into six classes (tissue) types. 
 
 FLAIR SPGR-precontrast T2 
 
SPGR-Gd    FCM Image 
 
Figure A-6: MRI volume data sets at another slice location segmented into six classes (tissue) types. 
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 Normal subject (N4): Inputs to FCM (FLAIR, T2, SPGR, SPGRGD) 
 FLAIR SPGR-precontrast T2 
 
SPGR-Gd    FCM Image 
 
Figure A-7: MRI volume data sets segmented into six classes (tissue) types. 
 
 FLAIR SPGR-precontrast T2 
 
SPGR-Gd     FCM Image 
 
Fig A-8: MRI volume data sets at another slice location segmented into six classes (tissue) types. 
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 Tumor patient (P1): Inputs to FCM (FLAIR, T2, SPGR, SPGRGD) 
 FLAIR SPGR-precontrast T2 
 
SPGR-Gd    FCM Image 
 
Figure A-9: MRI volume data sets segmented into nine classes (tissue) types. 
 
 FLAIR SPGR-precontrast T2 
 
SPGR-Gd    FCM Image 
 
Figure A-10: MRI volume data sets at another slice location segmented into nine classes (tissue) types. 
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 Tumor patient (P2): Inputs to FCM (FLAIR, T2, SPGR, SPGRGD) 
 FLAIR SPGR-precontrast T2 
 
SPGR-Gd    FCM Image 
 
Figure A-11: MRI volume data sets segmented into nine classes (tissue) types. 
 
 FLAIR SPGR-precontrast T2  
 
SPGR-Gd    FCM Image 
 
Figure A-12: MRI volume data sets at another slice location segmented into nine classes (tissue) types. 
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 Tumor patient (P3): Inputs to FCM (FLAIR, T2, SPGR, SPGRGD) 
 FLAIR SPGR-precontrast T2 
 
SPGR-Gd    FCM Image 
 
Figure A-13: MRI volume data sets segmented into nine classes (tissue) types. 
 
 FLAIR SPGR-precontrast T2 
 
SPGR-Gd    FCM Image 
 
Figure A-14: MRI volume data sets at another slice location segmented into nine classes (tissue) types. 
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 Tumor patient(P4): Inputs to FCM (FLAIR, T2, SPGR, SPGRGD) 
 FLAIR SPGR-precontrast T2 
 
SPGR-Gd    FCM Image 
 
Figure A-15: MRI volume data sets segmented into nine classes (tissue) types. 
 
 FLAIR SPGR-precontrast T2 
 
SPGR-Gd    FCM Image 
 
Figure A-16: MRI volume data sets at another slice location segmented into nine classes (tissue) types. 
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 Normal subject (N1): Comparison between FCM and SPM segmented images. 
 W CSF FCM: GRAY MATTER HITE MATTER 
 
 FLAIR SPGRGd T2 
 
SPM: GRAY MATTER WHITE MATTER CSF 
 
Diff. image:  GRAY MATTER WHITE MATTER CSF 
 
Figure A-17: Comparison of tissues between FCM and SPM segmentation of N1. 
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 Normal subject (N2): Comparison between FCM and SPM segmented images. 
FCM: GRAY MATTER WHITE MATTER CSF 
 
 FLAIR SPGR-Gd T2 
 
SPM: GRAY MATTER WHITE MATTER CSF 
 
Diff. image: GRAY MATTER WHITE MATTER CSF 
 
Figure A-18: Comparison of tissues between FCM and SPM segmentation of N2.  
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 Normal subject (N3): Comparison between FCM and SPM segmented images. 
FCM: GRAY MATTER WHITE MATTER CSF 
 
 FLAIR SPGR Gd T2 
 
SPM: GRAY MATTER WHITE MATTER CSF 
 
Diff. image: GRAY MATTER WHITE MATTER CSF 
 
Figure A-19: Comparison of tissues between FCM and SPM segmentation of N3. 
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 Normal subject (N4): Comparison between FCM and SPM segmented images. 
FCM: GRAY MATTER WHITE MATTER CSF 
 
 FLAIR SPGR Gd T2 
 
SPM: GRAY MATTER WHITE MATTER CSF 
 
Diff. image: GRAY MATTER WHITE MATTER CSF 
 
Figure A-20: Comparison of tissues between FCM and SPM segmentation of N4. 
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 Tumor patient (P1): Comparison between FCM and SPM segmented images 
FCM: GRAY MATTER WHITE MATTER CSF 
 
 FLAIR SPGR Gd T2 
 
SPM: GRAY MATTER WHITE MATTER CSF 
 
Diff. image:  GRAY MATTER WHITE MATTER CSF 
Figure A-21: Comparison of tissues between FCM and SPM segmentation of P1. 
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 Tumor patient (P2): Comparison between FCM and SPM segmented images. 
FCM: GRAY MATTER WHITE MATTER CSF 
 
 FLAIR SPGR Gd T2 
 
SPM: GRAY MATTER WHITE MATTER CSF 
 
Diff. image: GRAY MATTER WHITE MATTER CSF 
 
Figure A-22: Comparison of tissues between FCM and SPM segmentation of P2. 
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 Tumor patient (P3): Comparison between FCM and SPM segmented images. 
FCM: GRAY MATTER WHITE MATTER CSF 
 
 FLAIR SPGR Gd T2 
 
SPM: GRAY MATTER WHITE MATTER CSF 
 
Diff. image: GRAY MATTER WHITE MATTER CSF 
 
Figure A-23: Comparison of tissues between FCM and SPM segmentation of P3. 
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 Tumor patient (P4): Comparison between FCM and SPM segmented images. 
FCM: GRAY MATTER WHITE MATTER CSF 
   
 FLAIR SPGR Gd T2 
   
SPM: GRAY MATTER WHITE MATTER CSF 
 
Diff. image: GRAY MATTER WHITE MATTER CSF 
 
Figure A-24: Comparison of tissues between FCM and SPM segmentation of P4.  
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 Normal subject (N1): Inputs to FCM (FLAIR, T2, SPGR, SPGRGD, DWI) 
 FLAIR SPGR-precontrast T2 
 
CM Image 
 
A-25: ets segme (tissue) types. 
 
 FLAIR SPGR-precontrast T2 
 
SPGR-Gd  DWI FCM Image 
 
Figure A-26: MRI volume data sets segmented into six classes (tissue) types. 
SPGR-Gd  DWI F
Figure  MRI volume data s nted into six classes 
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 Normal subject (N2): Inputs to FCM (FLAIR, T2, SPGR, SPGRGD, DWI)  
 FLAIR SPGR-precontrast T2 
 
SPGR-Gd DWI FCM Image 
 
Figure A-27: MRI volume data sets segmented into six classes (tissue) types. 
 
 FLAIR SPGR-precontrast T2 
 
SPGR-Gd  DWI FCM Image 
 
Figure A-28: MRI volume data sets segmented into six classes (tissue) types. 
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 Normal subject (N3): Inputs to FCM (FLAIR, T2, SPGR, SPGRGD, DWI)  
 FLAIR SPGR-precontrast T2 
 
SPGR-GD DWI FCM image 
 
Figure A-29: MRI volume data sets segmented into six classes (tissue) types. 
 
 FLAIR SPGR-precontrast T2 
 
SPGR-GD DWI FCM image 
 
Figure A-30: MRI volume data sets segmented into six classes (tissue) types. 
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 Normal subject (N4): Inputs to FCM (FLAIR, T2, SPGR, SPGRGD, DWI)  
 FLAIR SPGR-precontrast T2 
 
SPGR-GD DWI FCM image 
 
Figure A-31: MRI volume data sets segmented into six classes (tissue) types. 
 
 FLAIR SPGR-precontrast T2 
 
 SPGR-GD DWI FCM image 
 
Figure A-32: MRI volume data sets segmented into six classes (tissue) types. 
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Tumor patient (P1): Inputs to FCM (FLAIR, T2, SPGR, SPGRGD, DWI)  
 
 
 FLAIR SPGR-precontrast T2 
 
SPGR-GD DWI FCM image  
 
Figure A-33: MRI volume data sets segmented into nine classes (tissue) types.
Tumor patient (P2): Inputs to FCM (FLAIR, T2, SPGR, SPGRGD, DWI)  
 FLAIR SPGR-precontrast T2 
 
 SPGR-GD DWI FCM image 
 
Figure A-34: MRI volume data sets segmented into nine classes (tissue) types.
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 Tumor patient (P3): Inputs to FCM (FLAIR, T2, SPGR, SPGRGD, DWI)  
T  
 
 SPGR-GD DWI FCM image 
 
Figure A-35: MRI volume data sets segmented into nine classes (tissue) types. 
 FLAIR SPGR-precontrast 2
 82
 Normal subject (N1): Comparison between FCM and SPM segmented images using five 
W CSF 
 
SPGR-GD 
 
CSF 
 
Diff. image: GRAY MATTER WHITE MATTER CSF 
 
Figure A-36 Comparison of FCM and SPM segmented images using five feature vectors 
feature vectors. 
FCM: GRAY MATTER HITE MATTER 
 FLAIR DWI 
SPM: GRAY MATTER WHITE MATTER 
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 Normal subject (N2): Comparison between FCM and SPM segmented images using five 
feature vectors. 
FCM: GRAY MATTER WHITE MATTER CSF 
 
 FLAIR DWI SPGR-GD 
 
SPM: GRAY MATTER WHITE MATTER CSF 
 
Diff. image: GRAY MATTER WHITE MATTER CSF 
 
Figure A-37  Comparison of FCM and SPM segmented images using five feature vectors 
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 Normal subject (N3): Comparison between FCM and SPM segmented images using five 
feature vectors. 
FCM: GRAY MATTER WHITE MATTER CSF 
 
 FLAIR DWI SPGR-GD 
 
SPM: GRAY MATTER WHITE MATTER CSF 
 
Diff. image: GRAY MATTER WHITE MATTER CSF 
 
Figure A-38  Comparison of FCM and SPM segmented images using five feature vectors 
 85
 Normal subject (N4): Comparison between FCM and SPM segmented images using five 
feature vectors. 
FCM: GRAY MATTER WHITE MATTER CSF 
 
 FLAIR DWI SPGR-GD 
 
SPM: GRAY MATTER WHITE MATTER CSF 
 
Diff. image: GRAY MATTER WHITE MATTER CSF 
 
Figure A-39  Comparison of FCM and SPM segmented images using five feature vectors 
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 Tumor patient (P1): Comparison between FCM and SPM segmented images using five 
feature vectors. 
FCM: GRAY MATTER WHITE MATTER CSF 
 
 FLAIR DWI SPGR-GD 
 
SPM: GRAY MATTER WHITE MATTER CSF 
 
Diff image: GRAY MATTER WHITE MATTER CSF 
 
Figure A-40  Comparison of FCM and SPM segmented images using five feature vectors 
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 Tumor patient (P2): Comparison between FCM and SPM segmented images using five 
feature vectors. 
FCM: GRAY MATTER WHITE MATTER CSF 
 
 FLAIR DWI SPGR-GD 
 
SPM: GRAY MATTER WHITE MATTER CSF 
 
Diff image: GRAY MATTER WHITE MATTER CSF 
 
Figure A-41  Comparison of FCM and SPM segmented images using five feature vectors 
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 Tumor patient (P3): Comparison between FCM and SPM segmented images using five 
feature vectors. 
FCM: GRAY MATTER WHITE MATTER CSF 
 
 FLAIR DWI SPGR-GD 
 
SPM: GRAY MATTER WHITE MATTER CSF 
 
Diff image: GRAY MATTER WHITE MATTER CSF 
 
Figure A-42: Comparison of FCM and SPM segmented images using five feature vectors. 
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